'Well positioned on the AI space and the expanded industrialization of the U.S.': Peers on Hubbell

Key Concepts

• Hubbell Incorporated (HUBB): A US-based manufacturer of electrical components, positioned to benefit from grid modernization and re-industrialization.
• Vertiv (VRT): A company specializing in power and cooling solutions for data centers, particularly focused on liquid cooling technology.
• Boston Scientific (BSX): A medical device company focused on cardiovascular and neurovascular treatments, benefiting from an aging global population.
• Re-industrialization/Deglobalization: The trend of bringing manufacturing back to domestic markets (specifically the US and Europe).
• Hyperscalers: Companies that operate large-scale data centers (e.g., Nvidia, Broadcom).
• Capital Expenditure (Capex): Funds used by a company to acquire, upgrade, and maintain physical assets such as buildings, machinery, and equipment.

Global Stock Picks: A Detailed Analysis

Hubbell Incorporated (HUBB) – Riding the Wave of Power Demand

Yens Pierce, CIO and Portfolio Manager at Marova US, identifies Hubbell Incorporated as a key investment opportunity. The core thesis revolves around the escalating demand for power, fueled by two primary drivers: the electrification of the grid (driven by electric vehicles and renewable energy sources) and the resurgence of US industrialization. Hubbell, with a market capitalization of approximately $26 billion, is described as a “pure play” on electrical components for utilities.

Pierce highlights the increasing need to upgrade the US power grid, not only to accommodate new demand but also to improve resilience against severe weather events and potential blackouts. He emphasizes that the US market is relatively protected, making it difficult for European competitors to gain significant market share due to established relationships between utilities and existing suppliers.

The re-industrialization trend, spurred by policies aimed at bringing manufacturing back to the US, is a significant catalyst. President Trump’s initiatives to incentivize domestic production and attract foreign companies to manufacture within the US are driving the construction of new factories, all requiring substantial power and water infrastructure. Pierce anticipates power generation growth to accelerate to between 2-5% annually for at least the next one to two decades, necessitating significant grid expansion. This increased demand is not solely attributable to AI and electrification but also to the broader expansion of US industrial capacity.

Vertiv (VRT) – A Safe Bet on AI and Data Center Growth

Vertiv is presented as a compelling investment within the AI and data center space. The company has already experienced positive market performance and is positioned as a “pure play” with approximately 80% of its exposure tied to data centers. A key differentiator for Vertiv is its expertise in both air and liquid cooling technologies, with liquid cooling identified as the future of data center cooling.

Vertiv’s broad client base, encompassing all major “hyperscalers,” provides a diversified revenue stream. This ensures consistent involvement in capital expenditure cycles, regardless of individual client investment strategies. Furthermore, Vertiv is involved in the early stages of data center development, collaborating with companies like Nvidia and Broadcom on the design of cooling and power solutions for new GPUs and chips. This early involvement translates to a long investment cycle and a highly visible order book, suggesting sustained growth potential.

Boston Scientific (BSX) – Benefiting from Demographic Trends

Boston Scientific represents a departure from the industrial focus of the other two picks, centering instead on the healthcare sector. The investment rationale is rooted in global demographic trends, specifically the aging population and increased longevity, which are leading to a higher prevalence of cardiovascular and neurovascular issues.

The company is a market leader in devices for treating heart rhythm problems, and a recent acquisition in the neurovascular space expands its capabilities in stroke treatment and prevention. Pierce anticipates a significant catalyst in March with the expected publication of positive trial results for a new treatment aimed at preventing or addressing blood clots in the heart. He believes this treatment is likely to become a preferred option, leading to accelerated growth and an expanded addressable market. Specifically, approximately one in ten people globally suffer from heart rhythm issues, highlighting the substantial market opportunity.

Logical Connections & Synthesis

The three stock picks, while diverse in sector, are connected by a common thread: capitalizing on significant, long-term trends. Hubbell and Vertiv benefit from infrastructure demands driven by technological advancements (AI) and geopolitical shifts (re-industrialization). Boston Scientific leverages demographic changes and medical innovation. Pierce’s selections demonstrate a focus on companies positioned to benefit from structural shifts rather than short-term market fluctuations. He emphasizes the importance of identifying companies with strong market positions, protected markets (Hubbell), and long-term visibility (Vertiv).

Notable Quotes

• Yens Pierce: “Hubbell is a pure play on electrical components for utilities…there’s an enormous hunger for power these days.”
• Yens Pierce: “Vertive is a safe play on on AI and data centers.”
• Yens Pierce: “as our population gets older and we live longer uh the treatment of those will become a lot more uh important going forward.”

Data & Statistics

• Hubbell Market Cap: Approximately $26 billion.
• Power Generation Growth Expectation: 2-5% annually for the next one to two decades.
• Global Prevalence of Heart Rhythm Issues: Approximately 1 in 10 people.
• Vertiv Data Center Exposure: 80% of revenue.